MYC protein interactors in gene transcription and cancer

被引:216
作者
Lourenco, Corey [1 ]
Resetca, Diana [1 ,2 ]
Redel, Cornelia [1 ,2 ]
Lin, Peter [1 ,2 ]
MacDonald, Alannah S. [1 ,2 ]
Ciaccio, Roberto [3 ]
Kenney, Tristan M. G. [1 ,2 ]
Wei, Yong [1 ,4 ]
Andrews, David W. [2 ,4 ]
Sunnerhagen, Maria [5 ]
Arrowsmith, Cheryl H. [1 ,2 ,6 ]
Raught, Brian [1 ,2 ]
Penn, Linda Z. [1 ,2 ]
机构
[1] Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada
[3] Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy
[4] Sunnybrook Res Inst, Biol Sci, Toronto, ON, Canada
[5] Linkoping Univ, Dept Phys Chem & Biol, Linkoping, Sweden
[6] Struct Genom Consortium, Toronto, ON, Canada
关键词
HISTONE ACETYLTRANSFERASE COMPLEX; TATA-BINDING PROTEIN; RNA CAP METHYLATION; RECRUITS P-TEFB; C-MYC; TRANSACTIVATION DOMAIN; IN-VIVO; SELECTIVE-INHIBITION; ESSENTIAL COFACTOR; TERMINAL DOMAIN;
D O I
10.1038/s41568-021-00367-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The transcription factor and oncoprotein MYC is a potent driver of many human cancers and can regulate numerous biological activities that contribute to tumorigenesis. How a single transcription factor can regulate such a diverse set of biological programmes is central to the understanding of MYC function in cancer. In this Perspective, we highlight how multiple proteins that interact with MYC enable MYC to regulate several central control points of gene transcription. These include promoter binding, epigenetic modifications, initiation, elongation and post-transcriptional processes. Evidence shows that a combination of multiple protein interactions enables MYC to function as a potent oncoprotein, working together in a 'coalition model', as presented here. Moreover, as MYC depends on its protein interactome for function, we discuss recent research that emphasizes an unprecedented opportunity to target protein interactors to directly impede MYC oncogenesis. This Perspective highlights the importance of protein-protein interactions for the oncogenic functions of MYC and discusses how the MYC protein interactome might be exploited therapeutically.
引用
收藏
页码:579 / 591
页数:13
相关论文
共 164 条
[11]   A moving target: structure and disorder in pursuit of Myc inhibitors [J].
Bayliss, Richard ;
Burgess, Selena G. ;
Leen, Eoin ;
Richards, Mark W. .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2017, 45 :709-717
[12]   Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapy [J].
Beaulieu, Marie-Eve ;
Jauset, Toni ;
Masso-Valles, Daniel ;
Martinez-Martin, Sandra ;
Rahl, Peter ;
Maltais, Loika ;
Zacarias-Fluck, Mariano F. ;
Casacuberta-Serra, Silvia ;
Serrano del Pozo, Erika ;
Fiore, Christopher ;
Foradada, Laia ;
Castillo Cano, Virginia ;
Sanchez-Hervas, Meritxell ;
Guenther, Matthew ;
Romero Sanz, Eduardo ;
Oteo, Marta ;
Tremblay, Cynthia ;
Martin, Genesis ;
Letourneau, Danny ;
Montagne, Martin ;
Morcillo Alonso, Miguel Angel ;
Whitfield, Jonathan R. ;
Lavigne, Pierre ;
Soucek, Laura .
SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (484)
[13]   Coupling mRNA processing with transcription in time and space [J].
Bentley, David L. .
NATURE REVIEWS GENETICS, 2014, 15 (03) :163-175
[14]   MAX - A HELIX-LOOP-HELIX ZIPPER PROTEIN THAT FORMS A SEQUENCE-SPECIFIC DNA-BINDING COMPLEX WITH MYC [J].
BLACKWOOD, EM ;
EISENMAN, RN .
SCIENCE, 1991, 251 (4998) :1211-1217
[15]   Application of a MYC degradation screen identifies sensitivity to CDK9 inhibitors in KRAS-mutant pancreatic cancer [J].
Blake, Devon R. ;
Vaseva, Angelina V. ;
Hodge, Richard G. ;
Kline, McKenzie P. ;
Gilbert, Thomas S. K. ;
Tyagi, Vikas ;
Huang, Daowei ;
Whiten, Gabrielle C. ;
Larson, Jacob E. ;
Wang, Xiaodong ;
Pearce, Kenneth H. ;
Herring, Laura E. ;
Graves, Lee M. ;
Frye, Stephen V. ;
Emanuele, Michael J. ;
Cox, Adrienne D. ;
Der, Channing J. .
SCIENCE SIGNALING, 2019, 12 (590)
[16]   Transcription Factors Activate Genes through the Phase-Separation Capacity of Their Activation Domains [J].
Boija, Ann ;
Klein, Isaac A. ;
Sabari, Benjamin R. ;
Dall'Agnese, Alessandra ;
Coffey, Eliot L. ;
Zamudio, Alicia V. ;
Li, Charles H. ;
Shrinivas, Krishna ;
Manteiga, John C. ;
Hannett, Nancy M. ;
Abraham, Brian J. ;
Afeyan, Lena K. ;
Guo, Yang E. ;
Rimel, Jenna K. ;
Fant, Charli B. ;
Schuijers, Jurian ;
Lee, Tong Ihn ;
Taatjes, Dylan J. ;
Young, Richard A. .
CELL, 2018, 175 (07) :1842-+
[17]   Transcriptional Addiction in Cancer [J].
Bradner, James E. ;
Hnisz, Denes ;
Young, Richard A. .
CELL, 2017, 168 (04) :629-643
[18]   Reactivation of Myc transcription in the mouse heart unlocks its proliferative capacity [J].
Bywater, Megan J. ;
Burkhart, Deborah L. ;
Straube, Jasmin ;
Sabo, Arianna ;
Pendino, Vera ;
Hudson, James E. ;
Quaife-Ryan, Gregory A. ;
Porrello, Enzo R. ;
Rae, James ;
Parton, Robert G. ;
Kress, Theresia R. ;
Amati, Bruno ;
Littlewood, Trevor D. ;
Evan, Gerard, I ;
Wilson, Catherine H. .
NATURE COMMUNICATIONS, 2020, 11 (01)
[19]   MYC Regulation of Cell Growth through Control of Transcription by RNA Polymerases I and III [J].
Campbell, Kirsteen J. ;
White, Robert J. .
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2014, 4 (05)
[20]   ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development [J].
Cang, Shundong ;
Iragavarapu, Chaitanya ;
Savooji, John ;
Song, Yongping ;
Liu, Delong .
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2015, 8